These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16537903)

  • 1. Cyclin D3 maintains growth-inhibitory activity of C/EBPalpha by stabilizing C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.
    Wang GL; Shi X; Salisbury E; Sun Y; Albrecht JH; Smith RG; Timchenko NA
    Mol Cell Biol; 2006 Apr; 26(7):2570-82. PubMed ID: 16537903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone corrects proliferation and transcription of phosphoenolpyruvate carboxykinase in livers of old mice via elimination of CCAAT/enhancer-binding protein alpha-Brm complex.
    Wang GL; Shi X; Salisbury E; Sun Y; Albrecht JH; Smith RG; Timchenko NA
    J Biol Chem; 2007 Jan; 282(2):1468-78. PubMed ID: 17107955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ghrelin receptor (GHS-R1A) agonists show potential as interventive agents during aging.
    Smith RG; Sun Y; Jiang H; Albarran-Zeckler R; Timchenko N
    Ann N Y Acad Sci; 2007 Nov; 1119():147-64. PubMed ID: 18056963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDAC1 cooperates with C/EBPalpha in the inhibition of liver proliferation in old mice.
    Wang GL; Salisbury E; Shi X; Timchenko L; Medrano EE; Timchenko NA
    J Biol Chem; 2008 Sep; 283(38):26169-78. PubMed ID: 18622015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4.
    Wang H; Iakova P; Wilde M; Welm A; Goode T; Roesler WJ; Timchenko NA
    Mol Cell; 2001 Oct; 8(4):817-28. PubMed ID: 11684017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
    Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proline-histidine-rich CDK2/CDK4 interaction region of C/EBPalpha is dispensable for C/EBPalpha-mediated growth regulation in vivo.
    Porse BT; Pedersen TA; Hasemann MS; Schuster MB; Kirstetter P; Luedde T; Damgaard I; Kurz E; Schjerling CK; Nerlov C
    Mol Cell Biol; 2006 Feb; 26(3):1028-37. PubMed ID: 16428455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of cyclins D1 and D3 in hepatocyte proliferation.
    Rickheim DG; Nelsen CJ; Fassett JT; Timchenko NA; Hansen LK; Albrecht JH
    Hepatology; 2002 Jul; 36(1):30-8. PubMed ID: 12085346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of apoptotic and growth inhibitory activities of C/EBPalpha in different cell lines.
    Wang GL; Shi X; Salisbury E; Timchenko NA
    Exp Cell Res; 2008 Apr; 314(7):1626-39. PubMed ID: 18313667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lineage specific composition of cyclin D-CDK4/CDK6-p27 complexes reveals distinct functions of CDK4, CDK6 and individual D-type cyclins in differentiating cells of embryonic origin.
    Bryja V; Pacherník J; Vondráček J; Souček K; Čajánek L; Horvath V; Holubcová Z; Dvořák P; Hampl A
    Cell Prolif; 2008 Dec; 41(6):875-893. PubMed ID: 19040567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
    Kiess M; Gill RM; Hamel PA
    Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival.
    Wang H; Nicolay BN; Chick JM; Gao X; Geng Y; Ren H; Gao H; Yang G; Williams JA; Suski JM; Keibler MA; Sicinska E; Gerdemann U; Haining WN; Roberts TM; Polyak K; Gygi SP; Dyson NJ; Sicinski P
    Nature; 2017 Jun; 546(7658):426-430. PubMed ID: 28607489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dephosphorylated C/EBPalpha accelerates cell proliferation through sequestering retinoblastoma protein.
    Wang GL; Timchenko NA
    Mol Cell Biol; 2005 Feb; 25(4):1325-38. PubMed ID: 15684384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In prostate cancer C/EBPalpha promotes cell growth by the loss of interactions with CDK2, CDK4, and E2F and by activation of AKT.
    Yin H; Lowery M; Glass J
    Prostate; 2009 Jun; 69(9):1001-16. PubMed ID: 19347879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence.
    Lin J; Jinno S; Okayama H
    Oncogene; 2001 Apr; 20(16):2000-9. PubMed ID: 11360184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D3 is dispensable for human diffuse large B-cell lymphoma survival and growth: evidence for redundancy with cyclin E.
    Gumina MR; Xu C; Chiles TC
    Cell Cycle; 2010 Feb; 9(4):820-8. PubMed ID: 20107311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cyclin D-CDK6 dimer helps to reshuffle cyclin-dependent kinase inhibitors (CKI) to overcome TGF-beta-mediated arrest and maintain CDK2 activity.
    Nataraj SE; Blain SW
    Cell Cycle; 2021 Apr; 20(8):808-818. PubMed ID: 33794722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.